BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28966230)

  • 21. Impact of the 8th Edition of the UICC-TNM Classification on Clinical Stage 0-IA Lung Adenocarcinoma: Does the New Classification Predict Postoperative Prognosis More Precisely than the Previous One?
    Wang L; Anraku M; Sato M; Nitadori JI; Nagayama K; Kitano K; Nakajima J
    Ann Thorac Cardiovasc Surg; 2018 Oct; 24(5):223-229. PubMed ID: 29848840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors based on clinicopathological data among the patients with resected peripheral squamous cell carcinomas of the lung.
    Kinoshita T; Ohtsuka T; Hato T; Goto T; Kamiyama I; Tajima A; Emoto K; Hayashi Y; Kohno M
    J Thorac Oncol; 2014 Dec; 9(12):1779-87. PubMed ID: 25226427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
    Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
    Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Grading System Combining Tumor Budding and Nuclear Diameter Predicts Prognosis in Resected Lung Squamous Cell Carcinoma.
    Kadota K; Miyai Y; Katsuki N; Kushida Y; Matsunaga T; Okuda M; Yokomise H; Kanaji N; Bandoh S; Haba R
    Am J Surg Pathol; 2017 Jun; 41(6):750-760. PubMed ID: 28248819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
    Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completion pneumonectomy: a multicentre international study on 165 patients.
    Cardillo G; Galetta D; van Schil P; Zuin A; Filosso P; Cerfolio RJ; Forcione AR; Carleo F
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):405-9. PubMed ID: 22398467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes for oligometastasis in resected non-small cell lung cancer.
    Shimada Y; Saji H; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):937-44. PubMed ID: 26207006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.
    Wang BY; Huang JY; Chen HC; Lin CH; Lin SH; Hung WH; Cheng YF
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):43-52. PubMed ID: 31705294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
    Tsutani Y; Suzuki K; Koike T; Wakabayashi M; Mizutani T; Aokage K; Saji H; Nakagawa K; Zenke Y; Takamochi K; Ito H; Aoki T; Okami J; Yoshioka H; Okada M; Watanabe SI;
    Ann Thorac Surg; 2019 Nov; 108(5):1484-1490. PubMed ID: 31336067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.
    Ishikawa H; Nakayama Y; Kitamoto Y; Nonaka T; Kawamura H; Shirai K; Sakurai H; Hayakawa K; Niibe H; Nakano T
    Lung; 2006; 184(6):347-53. PubMed ID: 17086466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
    Hanprasertpong J; Jiamset I; Atjimakul T
    Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological Analysis of 17 Surgically Resected Pulmonary Pleomorphic Carcinoma Cases.
    Iijima Y; Nakajima Y; Kinoshita H; Nishimura Y; Iizuka T; Akiyama H; Hirata T
    Ann Thorac Cardiovasc Surg; 2021 Feb; 27(1):1-9. PubMed ID: 32493871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y
    Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.